Infrainguinal angioplasty with drug-eluting stents and balloons

Journal of Vascular Surgery

Volumn 59, Issue 6, 2014, Pages 1721-1736

  Canaud, Ludovic ^a   Ozdemir, Baris A ^a   Belli, Anna Maria ^a   Loftus, Ian M ^a   Thompson, Matt M ^a   Hinchliffe, Robert J ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

AMPUTATION; ANGIOPLASTY; ANKLE BRACHIAL INDEX; ARTICLE; BALLOON; BARE METAL STENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR THERAPEUTIC DEVICE; CLAUDICATION; COST EFFECTIVENESS ANALYSIS; CRITICAL LIMB ISCHEMIA; DRUG ELUTING BALLOON; DRUG ELUTING STENT; FEMOROPOPLITEAL ANGIOPLASTY; FOLLOW UP; HUMAN; INFRAPOPLITEAL ANGIOPLASTY; LEG ISCHEMIA; LIMB SALVAGE; META ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTENOSIS; REVASCULARIZATION; SURVIVAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; DRUG-ELUTING STENTS; HUMANS; INTERMITTENT CLAUDICATION; POPLITEAL ARTERY; PROSTHESIS DESIGN;

EID: 84900522924     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2014.03.235     Document Type: Review

References (44)

1. G. Dorros, M.R. Jaff, A.M. Dorros, L.M. Mathiak, and T. He Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up Circulation 104 2001 2057 2062
2. D.J. Adam, J.D. Beard, T. Cleveland, J. Bell, A.W. Bradbury, and J.F. Forbes et al. Bypass versus angioplasty in severe ischemia of the leg (BASIL): multicentre, randomised controlled trial Lancet 366 2005 1925 1934
3. M. Romiti, M. Albers, F.C. Brochado-Neto, A.E. Durazzo, C.A. Pereira, and N. De Luccia Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia J Vasc Surg 47 2008 975 981
4. M.C. Morice, P.W. Serruys, J.E. Sousa, J. Fajadet, E. Ban Hayashi, and M. Perin et al. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions N Engl J Med 346 2002 1773 1780
5. S. Garg, and P.W. Serruys Coronary stents: current status J Am Coll Cardiol 56 2010 1 42
6. A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gøtzsche, and J.P.A. Ioannidis et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
7. Higgins JPT, Green S, editors. The Cochrane handbook for systematic reviews of interventions version 5.1.0. Updated March 2011. The Cochrane Collaboration; 2011. Available at: www.cochrane-handbook.org.
8. A. Schmidt, M. Piorkowski, M. Werner, M. Ulrich, Y. Bausback, and S. Bräunlich et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome J Am Coll Cardiol 58 2011 1105 1109
9. G. Tepe, T. Zeller, T. Albrecht, S. Heller, U. Schwarzwälder, and J.P. Beregi et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
10. M. Werk, S. Langner, B. Reinkensmeier, H.F. Boettcher, G. Tepe, and U. Dietz et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 2008 1358 1365
11. A. Micari, A. Cioppa, G. Vadalà, F. Castriota, A. Liso, and A. Marchese et al. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry JACC Cardiovasc Interv 5 2012 331 338
12. D. Scheinert, M. Ulrich, S. Scheinert, J. Sax, S. Bräunlich, and G. Biamino Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions EuroIntervention 2 2006 169 174
13. P. Commeau, P. Barragan, and P.O. Roquebert Sirolimus for below the knee lesions: mid-term results of SiroBTK study Catheter Cardiovasc Interv 68 2006 793 798
14. M. Bosiers, K. Deloose, J. Verbist, and P. Peeters Percutaneous transluminal angioplasty for treatment of 'below-the-knee' critical limb ischemia: early outcomes following the use of sirolimus-eluting stents J Cardiovasc Surg (Torino) 47 2006 171 176
15. A.J. Feiring, and A.A. Wesolowski Antegrade popliteal artery approach for the treatment of critical limb ischemia in patients with occluded superficial femoral arteries Catheter Cardiovasc Interv 69 2007 665 670
16. O.R. Rosales, S. Mathewkutty, and C. Gnaim Drug eluting stents for below the knee lesions in patients with critical limb ischemia: long-term follow-up Catheter Cardiovasc Interv 72 2008 112 115
17. A.G. Grant, C.J. White, T.J. Collins, J.S. Jenkins, J.P. Reilly, and S.R. Ramee Infrapopliteal drug-eluting stents for chronic limb ischemia Catheter Cardiovasc Interv 71 2008 108 111
18. A.J. Feiring, M. Krahn, L. Nelson, A. Wesolowski, D. Eastwood, and A. Szabo Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial J Am Coll Cardiol 55 2010 1580 1589
19. R. Lookstein, T. Ward, E. Kim, A. Fischman, F. Nowakowski, and S. Ellozy et al. Value of drug-eluting stents after failed percutaneous transluminal angioplasty in the infrapopliteal vessels for the treatment of critical limb ischemia: favourable mid-term patency and limb salvage results J Cardiovasc Surg (Torino) 52 2011 461 466
20. A. Rastan, K. Brechtel, H. Krankenberg, R. Zahorsky, G. Tepe, and E. Noory et al. Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial J Am Coll Cardiol 60 2012 587 591
21. M. Bosiers, D. Scheinert, P. Peeters, G. Torsello, T. Zeller, and K. Deloose et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease J Vasc Surg 55 2012 390 398
22. D. Scheinert, K. Katsanos, T. Zeller, R. Koppensteiner, P. Commeau, and M. Bosiers et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial J Am Coll Cardiol 60 2012 2290 2295
23. S. Spiliopoulos, G. Fragkos, K. Katsanos, A. Diamantopoulos, D. Karnabatidis, and D. Siablis Long-term outcomes following primary drug-eluting stenting of infrapopliteal bifurcations J Endovasc Ther 19 2012 788 796
24. M. Werner, A. Schmidt, M. Freyer, Y. Bausback, S. Bräunlich, and J. Friedenberger et al. Sirolimus-eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia: long-term clinical and angiographic follow-up J Endovasc Ther 19 2012 12 19
25. S.H. Duda, B. Pusich, G. Richter, P. Landwehr, V.L. Oliva, and A. Tielbeek et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results Circulation 106 2002 1505 1509
26. S.H. Duda, M. Bosiers, J. Lammer, D. Scheinert, T. Zeller, and A. Tielbeek et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial J Vasc Interv Radiol 16 2005 331 338
27. M.D. Dake, D. Scheinert, G. Tepe, J. Tessarek, F. Fanelli, and M. Bosiers et al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study J Endovasc Ther 18 2011 613 623
28. M.D. Dake, G.M. Ansel, M.R. Jaff, T. Ohki, R.R. Saxon, and H.B. Smouse et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results Circ Cardiovasc Interv 4 2011 495 504
29. J. Lammer, M. Bosiers, T. Zeller, M. Schillinger, E. Boone, and M.J. Zaugg et al. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease J Vasc Surg 54 2011 394 401
30. M. Werk, T. Albrecht, D.-R. Meyer, M.N. Ahmed, A. Behne, and U. Dietz et al. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial Circ Cardiovasc Interv 5 2012 831 840
31. A. Falkowski, W. Poncyljusz, G. Wilk, and M. Szczerbo-Trojanowska The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries Eur Radiol 19 2009 966 974
32. D. Siablis, D. Karnabatidis, K. Katsanos, A. Diamantopoulos, S. Spiliopoulos, and G.C. Kagadis et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome J Vasc Interv Radiol 20 2009 1141 1150
33. G. Tepe, J. Schmehl, S. Heller, K. Brechtel, M. Heuschmid, and M. Fenchel et al. Drug eluting stents versus PTA with GP IIb/IIIa blockade below the knee in patients with current ulcers - the BELOW Study J Cardiovasc Surg (Torino) 51 2010 203 212
34. NICE Interventional Procedures Programme. Interventional procedure overview of percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial disease. IPG 433. Issued November 2012.
35. M.A. Rana, and P. Gloviczki Endovascular interventions for infrapopliteal arterial disease: an update Semin Vasc Surg 25 2012 29 34
36. C. Randon, B. Jacobs, F. De Ryck, and F. Vermassen Angioplasty or primary stenting for infrapopliteal lesions: results of a prospective randomized trial Cardiovasc Intervent Radiol 33 2010 260 269
37. M. Brodmann, H. Froehlich, A. Dorr, T. Gary, R.H. Portugaller, and H. Deutschmann et al. Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arteries in critical limb ischemia Vasa 40 2011 482 490
38. Schmidt A. INPACT DEEP: the Leipzig experience with drug-eluting balloons BTK. LINC 2012. Leipzig Interventional Course, January 25-28, 2012.
39. N.C. Schaper, G. Andros, J. Apelqvist, K. Bakker, J. Lammer, and M. Lepantalo et al. Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot Diabetes Metab Res Rev 28 2012 218 224
40. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI) P. Kolh, W. Wijns, N. Danchin, C. Di Mario, V. Falk, and T. Folliguet et al. Guidelines on myocardial revascularization Eur J Cardiothorac Surg 38 2010 1 52
41. D.I. Axel, W. Kunert, C. Goggelmann, M. Oberhoff, C. Herdeg, and A. Kuttner et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery Circulation 96 1997 636 645
42. B. Cortese, and A. Bertoletti Paclitaxel coated balloons for coronary artery interventions: a comprehensive review of preclinical and clinical data Int J Cardiol 161 2012 4 12
43. R.B. Rutherford, J.D. Baker, C. Ernst, K.W. Johnston, J.M. Porter, and S. Ahn et al. Recommended standards for reports dealing with lower extremity ischemia: revised version J Vasc Surg 26 1997 517 538
44. N. Diehm, I. Baumgartner, M. Jaff, D.D. Do, E. Minar, and J. Schmidli et al. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischemia of lower limb arteries Eur Heart J 28 2007 798 805